Početna › Rak (sve vrste) › Texas › Irving
Kliničke studije za Rak (sve vrste) u gradu Irving, TX
15 studija za Rak (sve vrste) traži sudionike na lokacijama u gradu Irving i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
REC-7735 in Participants With Solid Tumors
U tijeku regrutacijaFaza 1/2
- NEXT Oncology - Dallas, Irving
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
U tijeku regrutacijaFaza 1
- NEXT Dallas, Irving
Registry Study for Radiation Therapy Outcomes
U tijeku regrutacijaOpažajna studija
- Texas Center for Proton Therapy, Irving
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
U tijeku regrutacijaFaza 3
- US Oncology Research Investigational Products Center, Irving
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
U tijeku regrutacijaFaza 1/2
- NEXT Dallas, Irving
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
U tijeku regrutacijaFaza 1
- NEXT Oncology ( Site 0051), Irving
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
U tijeku regrutacijaFaza 1/2
- NEXT Oncology ( Site 1012), Irving
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
U tijeku regrutacijaFaza 1/2
- NEXT Oncology Dallas, Irving
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
U tijeku regrutacijaFaza 1
- NEXT Oncology Dallas, Irving
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
U tijeku regrutacijaFaza 1
- NEXT Dallas, Irving
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
U tijeku regrutacijaFaza 1
- NEXT Dallas, Irving
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
U tijeku regrutacijaFaza 1/2
- NEXT Oncology, Irving
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
U tijeku regrutacijaFaza 1
- NEXT Oncology, Irving
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
U tijeku regrutacijaFaza 1/2
- NEXT Dallas, Irving
Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up
U tijeku regrutacijaOpažajna studija
- Texas Center for Proton Therapy, Irving
Studije za Rak (sve vrste) u drugim gradovima
- Houston, TX121 studija
- New York City, NY110 studija
- Boston, MA86 studija
- Los Angeles, CA73 studija
- Nashville, TN65 studija
- Philadelphia, PA59 studija
- Durham, NC58 studija
- Washington, DC58 studija
- Chicago, IL51 studija
- Seattle, WA49 studija
- Atlanta, GA49 studija
- Arlington, VA48 studija
Ostale studije u gradu Irving
- Nemikrocelularni karcinom pluća22 studija
- Kolorektalni rak13 studija
- Metastatski karcinom11 studija
- Rak gušterače7 studija
- Rak želuca7 studija
- Pločastostanični karcinom glave i vrata6 studija
- Rak dojke6 studija
- Mikrocelularni karcinom pluća6 studija
- Rak pluća6 studija
- Rak jajnika5 studija
- Rak endometrija4 studija
- Rak prostate4 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.